Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu CN, Ojal J, Selim R, Ombati R, Akech D, Karia B, Tuju J, Sigilai A, Smits G, van Gageldonk PGM, van der Klis FRM, Flasche S, Kagucia EW, Scott JAG, Adetifa IMO
Vaccine, (2025). 61:127425

Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.Adetifa IMO, Karia B, Mutuku A, Bwanaali T, Makumi A, Wafula J, Chome M, Mwatsuma P, Bauni E, Hammitt LL, Mataza C, Tabu C, Kamau T, Williams TN, Scott JAG
Vaccine, (2018). 36:7965-7974